Elizabeth (Liz) Parrish MBA, is the Founder and CEO of BioViva Sciences USA Inc. BioViva is committed to extending healthy lifespans using gene therapy. BioViva works on combinatorial gene therapies with its proprietary CMV gene therapy delivery platform. Liz is a humanitarian, entrepreneur, author, and innovator. She is a proponent of the Best Choice Medicine plan (BCM), a more efficient and streamlined regulatory model around the use of genetic therapies. She is actively involved in international educational media outreach and is a founding member of several 501(c)(3) nonprofits in the space. She considers aging a disease and believes the advancements in space will lead to healthier and longer lifespans with the added benefit of safer space travel and curative medicine for patients under 20.From CHAT GPT -Liz Parrish is an entrepreneur and biohacker who is the founder and CEO of BioViva Sciences, a biotechnology company focused on developing gene therapies to treat age-related diseases. She is known for being the first person to undergo gene therapy to reverse biological aging, a procedure that was performed on her own body in 2015.Parrish is a strong advocate for the use of gene therapies to improve human health and extend lifespan. She has spoken extensively about the potential of genetic engineering to address diseases such as cancer, Alzheimer's, and heart disease and has been involved in a number of research initiatives aimed at developing new gene therapies. Parrish is also an active member of the global biohacking community and has been involved in various initiatives aimed at promoting the responsible use of genetic engineering technologies.
Listed skills include Biotechnology, Research, Science, Leadership, and 46 others.
